JP Morgan Chase
IMGN

JP Morgan Chase’s Immunogen Inc IMGN Stock Holding History

JP Morgan Chase’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100
Closed -$1.89K – 7805
2023
Q2 		$1.89K Sell
100
-186,600
-100% -$2.2M ﹤0.01% 6350
2023
Q1 		$717K Buy
+186,700
New +$796K ﹤0.01% 4270
2022
Q1 		– Sell
-31,700
Closed -$235K – 7136
2021
Q4 		$235K Buy
31,700
+30,700
+3,070% +$191K ﹤0.01% 5262
2021
Q3 		$6K Buy
+1,000
New +$5.78K ﹤0.01% 6237
2019
Q2 		– Sell
-363,600
Closed -$985K – 6077
2019
Q1 		$985K Buy
363,600
+150,000
+70% +$650K ﹤0.01% 3815
2018
Q4 		$1.02M Sell
213,600
-342,800
-62% -$2.08M ﹤0.01% 3734
2018
Q3 		$5.27M Buy
+556,400
New +$5.35M ﹤0.01% 2701

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's IMGN Position: Q1 2024 in Review

JP Morgan Chase sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,063,254 shares — an estimated $61.2M sold.

JP Morgan Chase first reported a position in IMGN in Q2 2013 and held it in 34 quarters. The position peaked at $61.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • JP Morgan Chase reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2,063,254 Immunogen Inc shares in Q1 2024, an estimated $61.2M.
  • JP Morgan Chase first reported a position in Immunogen Inc in Q2 2013 and held it in 34 quarters.
  • JP Morgan Chase's Immunogen Inc position peaked at $61.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.